<DOC>
	<DOCNO>NCT01517607</DOCNO>
	<brief_summary>This non-interventional study examine whether patient 's level information consideration patient 's preference positive effect compliance thus also therapeutic success .</brief_summary>
	<brief_title>Mesalazine ( PENTASA® ) Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Patients treat first time oral PENTASA® , e.g . follow first diagnosis ulcerative colitis treatment acute episode Following therapyfree period ( previous mesalazine therapy ) due poor response underdosage oder lack acceptance previous medication patient readjust oral PENTASA® , The patient ( ≥ 18 year ) inform NIS give write consent participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>